Financhill
Back

VYNE Therapeutics, Inc. Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison

Buy
56

VYNE
VYNE Therapeutics, Inc.

Last Price:
$0.57
Seasonality Move:
-5.82%
Sell
38

CRNX
Crinetics Pharmaceuticals, Inc.

Last Price:
$53.22
Seasonality Move:
-13.28%
Buy
56
VYNE Therapeutics, Inc. (VYNE) is a Buy

Is VYNE Therapeutics, Inc. a Buy, Sell or Hold?

  • The current VYNE Therapeutics, Inc. [VYNE] share price is $0.56. The Score for VYNE is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • VYNE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
38
Crinetics Pharmaceuticals, Inc. (CRNX) is a Sell

Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.34. The Score for CRNX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VYNE Stock Price Chart

What is VYNE Therapeutics, Inc.'s stock price today?

  • The VYNE Therapeutics, Inc. share price today is $0.56
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VYNE is experiencing slight buying pressure.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals, Inc.'s stock price today?

  • The Crinetics Pharmaceuticals, Inc. share price today is $53.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing buying pressure, which is a positive indicator for future bullish movement.

VYNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.14 Buy
Relative Strength Index (14 RSI): 62.86 Buy
Chaikin Money Flow: -57573 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.38 - 0.58) Buy
Bollinger Bands (100): (0.3 - 0.46) Buy

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.96 Buy
Relative Strength Index (14 RSI): 66.03 Buy
Chaikin Money Flow: 3428689 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.13 - 49.63) Buy
Bollinger Bands (100): (35.09 - 47.19) Buy

VYNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.57 Sell
20-day SMA: 0.51 Buy
50-day SMA: 0.42 Buy
200-day SMA: 0.81 Sell
8-day EMA: 0.54 Buy
20-day EMA: 0.42 Buy
50-day EMA: 0.23 Buy
200-day EMA: 0.07 Buy

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.2 Buy
20-day SMA: 48.28 Buy
50-day SMA: 45.42 Buy
200-day SMA: 36 Buy
8-day EMA: 48.68 Buy
20-day EMA: 47.84 Buy
50-day EMA: 45.56 Buy
200-day EMA: 40.15 Buy

VYNE Therapeutics, Inc. Earnings Growth & VYNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.21 per share, and a decrease next year of $0.55 per share.

Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.51 per share.

VYNE Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):